Inhibiting the Jumonji family: a potential new clinical approach to targeting aberrant epigenetic mechanisms. [electronic resource]
- Epigenomics Mar 2016
- 313-6 p. digital
Publication Type: Editorial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't